Papadimitriou GN - Search Results

1

Blunted TSH response to TRH and seizure duration in ECT.

Papakostas YG, Markianos M, Pehlivanidis A, Zervas IM, Papadimitriou GN, Stefanis C. Papakostas YG, et al. Among authors: papadimitriou gn. Acta Psychiatr Scand. 1999 Jan;99(1):68-72. doi: 10.1111/j.1600-0447.1999.tb05386.x. Acta Psychiatr Scand. 1999. PMID: 10066009 Clinical Trial.

2

Thyrotropin and prolactin responses to ECT in schizophrenia and depression.

Papakostas Y, Markianos M, Papadimitriou G, Lykouras L, Stefanis C. Papakostas Y, et al. Psychiatry Res. 1991 Apr;37(1):5-10. doi: 10.1016/0165-1781(91)90101-t. Psychiatry Res. 1991. PMID: 1862162

3

Ritanserin, a 5-HT2 receptor antagonist, does not modify ECT-induced prolactin release.

Papakostas Y, Markianos M, Papadimitriou G, Stefanis C. Papakostas Y, et al. Psychopharmacology (Berl). 1990;100(2):206-8. doi: 10.1007/BF02244407. Psychopharmacology (Berl). 1990. PMID: 2106150

4

Prolactin and thyrotropin responses to ECT after pindolol administration. A placebo controlled study.

Papakostas Y, Markianos M, Papadimitriou G, Stefanis N, Lykouras L, Stefanis C. Papakostas Y, et al. Eur Neuropsychopharmacol. 1993 Mar;3(1):75-9. doi: 10.1016/0924-977x(93)90297-y. Eur Neuropsychopharmacol. 1993. PMID: 8471832 Clinical Trial.

5

Effects of methysergide and ritanserin on the prolactin and thyrotropin responses to TRH in depressed patients.

Papakostas YG, Markianos M, Papadimitriou GN, Zervas IM, Stefanis CN. Papakostas YG, et al. Among authors: papadimitriou gn. Eur Neuropsychopharmacol. 1995 Mar;5(1):15-8. doi: 10.1016/0924-977x(94)00126-v. Eur Neuropsychopharmacol. 1995. PMID: 7613098 Clinical Trial.

6

Effects of thyrotropin-releasing hormone administration on the electroconvulsive therapy induced prolactin responses and seizure time.

Papakostas Y, Markianos M, Pehlivanidis A, Papadimitriou GN, Zervas IM, Daras M, Stefanis C. Papakostas Y, et al. Among authors: papadimitriou gn. Biol Psychiatry. 1996 Mar 15;39(6):444-7. doi: 10.1016/0006-3223(95)00198-0. Biol Psychiatry. 1996. PMID: 8679790 Clinical Trial.

7

Effects of TRH administration on orientation time and recall after ECT.

Zervas IM, Pehlivanidis AA, Papakostas YG, Markianos M, Papadimitriou GN, Stefanis CN. Zervas IM, et al. Among authors: papadimitriou gn. J ECT. 1998 Dec;14(4):236-40. J ECT. 1998. PMID: 9871843 Clinical Trial.

8

Electrode Placement and Prolactin Response to Electroconvulsive Therapy.

Papakostas Y, Stefanis C, Markianos M, Papadimitriou G. Papakostas Y, et al. Convuls Ther. 1986;2(2):99-107. Convuls Ther. 1986. PMID: 11940852

9

Thyrotropin and Prolactin Secretion During ECT: Implications for the Mechanism of ECT Action.

Papakostas Y, Markianos M, Papadimitriou G, Stefanis C. Papakostas Y, et al. Convuls Ther. 1990;6(3):214-220. Convuls Ther. 1990. PMID: 11941070

10

A survey of the attitudes of Greek medical students toward electroconvulsive therapy.

Papakosta VM, Zervas IM, Pehlivanidis A, Papadimitriou GN, Papakostas YG. Papakosta VM, et al. Among authors: papadimitriou gn. J ECT. 2005 Sep;21(3):162-4. doi: 10.1097/01.yct.0000170036.13610.a9. J ECT. 2005. PMID: 16127305

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

231 results

Search Page